Monashee Investment Management
$24M 13F equity value
30 Holdings
Quarter ended September 30, 2026
The latest 13F on file for Monashee Investment Management covers the quarter ended September 30, 2026. Institutional managers report holdings quarterly to the SEC, so each filing is a snapshot of positions held on that date.
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| IMMX | IMMIX BIOPHARMA INC | 450,000 | $5M | 19.7% |
| SYY | SYSCO CORP | 55,000 | $4M | 18.0% |
| ADT | ADT INC DEL | 500,000 | $3M | 12.8% |
| SLDB | SOLID BIOSCIENCES INC | 410,000 | $3M | 12.5% |
| ENB | ENBRIDGE INC | 50,000 | $2M | 9.8% |
| BLSM | BLOSSOMHILL THERAPEUTICS INC | 80,000 | $1M | 6.3% |
| ETRA | ELECTRA THERAPEUTICS INC | 100,000 | $1M | 4.7% |
| YARW | YARROW BIOSCIENCE INC | 40,000 | $900,800 | 3.8% |
| IMA | IMAGENEBIO INC | 177,094 | $811,091 | 3.4% |
| AVAH | AVEANNA HEALTHCARE HLDGS INC | 50,000 | $620,500 | 2.6% |
Track Monashee Investment Management's 13F portfolio: $24M in reported holdings, 30 positions. Top holdings and quarterly changes on SentiSense.
This page is powered by the SentiSense API: GET /api/v1/institutional/institution/{slugOrCik}